key: cord-0024910-u9a5n3sk authors: Guo, Xiaoyi; Zhou, Wei; Yu, Yan; Cai, Yinghua; Zhang, Yuan; Du, Aiyan; Lu, Qun; Ding, Yijie; Li, Chao title: Multiple Laplacian Regularized RBF Neural Network for Assessing Dry Weight of Patients With End-Stage Renal Disease date: 2021-12-13 journal: Front Physiol DOI: 10.3389/fphys.2021.790086 sha: 747134ded59ceb6cf0214e8bfd0baed4265080c4 doc_id: 24910 cord_uid: u9a5n3sk Dry weight (DW) is an important dialysis index for patients with end-stage renal disease. It can guide clinical hemodialysis. Brain natriuretic peptide, chest computed tomography image, ultrasound, and bioelectrical impedance analysis are key indicators (multisource information) for assessing DW. By these approaches, a trial-and-error method (traditional measurement method) is employed to assess DW. The assessment of clinician is time-consuming. In this study, we developed a method based on artificial intelligence technology to estimate patient DW. Based on the conventional radial basis function neural (RBFN) network, we propose a multiple Laplacian-regularized RBFN (MLapRBFN) model to predict DW of patient. Compared with other model and body composition monitor, our method achieves the lowest value (1.3226) of root mean square error. In Bland-Altman analysis of MLapRBFN, the number of out agreement interval is least (17 samples). MLapRBFN integrates multiple Laplace regularization terms, and employs an efficient iterative algorithm to solve the model. The ratio of out agreement interval is 3.57%, which is lower than 5%. Therefore, our method can be tentatively applied for clinical evaluation of DW in hemodialysis patients. Dry weight (DW) refers to a patient's target weight after the end of dialysis (Grassmann et al., 2000; Wabel et al., 2009) . After removing excess water from the body, the patient had no facial swelling, wheezing or sitting breathing, edema of both lower limbs, and distended jugular vein (Alexiadis et al., 2016) . The patient's blood pressure, heart rate, breathing, and other vital signs are stable. There are individual differences in the specific value of DW. Good dry weight control can effectively reduce adverse reactions during dialysis. At present, the DW of hemodialysis patients is mainly evaluated by clinical means. This method is labor-intensive and time-consuming, and requires repeated use of various clinical instruments and biological indicators to complete the evaluation. In the past 10 years, a measuring instrument based on human bioelectrical impedance analysis (BIA), called body composition monitor (BCM) (Jiang et al., 2017) , has been accurately determining the DW of patients. The above methods require professionals and cannot be processed on a large scale. In recent years, artificial intelligence technology has been widely utilized in the biomedical field (Chen et al., 2019; Cheng et al., 2019; Lin, 2020; Zhang, 2020; Hu et al., 2021a) . Artificial neural networks (ANNs) based on back propagation (BP) were employed to evaluate the total water volume of hemodialysis patients. Compared with conventional clinical calculation equations (Chiu et al., 2005) , the ANNs obtained better results. Deep learning (Dao et al., 2021; Lv et al., 2021a,b) also made a great contribution to the clinic, including skin cancer (Esteva et al., 2017) , breast cancer (Liu J. et al., 2021) , and brain diseases (Liu G. et al., 2018; Liu et al., 2019; Bi et al., 2020; Hu et al., 2020 Hu et al., , 2021a . In biological field, machine learning has been widely used to solve biological problems, including O-GlcNAcylation site prediction (Jia et al., 2018) , microbiology analysis (Qu et al., 2019) , microRNAs and cancer association prediction (Zeng et al., 2018) , lncRNAs (Cheng et al., 2016; Deng et al., 2021) , CircRNAs (Fang et al., 2019; Zhao et al., 2019) , DNA methylation site (Wei et al., 2018b; Zou et al., 2019; Dai et al., 2020) , osteoporosis diagnoses , function prediction of proteins (Wei et al., 2018a; Wang H. et al., 2019; Deng et al., 2020b; Ding et al., 2020a; Su et al., 2020a) , nucleotide binding sites , drug complex network analysis (Ding et al., 2019 (Ding et al., , 2020b Deng et al., 2020a; Han et al., 2021; Liu H. et al., 2021) , protein remote homology (Liu B. et al., 2018) , electron transport proteins (Ru et al., 2019) , and cellspecific replication. In this study, we proposed a novel predictive model based on radial basis function neural network (RBFN). Different from RBFN, multiple Laplacian-regularized RBFN (MLapRBFN) is a multi-view Laplacian regularized model with L 2 , 1 -norm, which introduces multiple graph regular items. The Laplacian regular items consider the topological relationship between each patient. The data set of this study came from the hemodialysis center of Wuxi and the northern Jiangsu People's Hospital. Our study was approved by the ethics committees (Nos. 2018KY-001 and KYLLKS201813). There are a total of 476 hemodialysis patients. These patients meet the following conditions: over 18 years old; more than 3 months end-stage renal disease (ESRD) and maintenance hemodialysis; diseases such as metal implants, infections, heart failure, disability, pregnancy, and edema, do not appear in the patient population. DW is determined by clinical scoring, which is based on brain natriuretic peptide (BNP), chest computed tomography (CT) image, ultrasound, and bioelectrical impedance analysis (BIA). In addition, age, gender, diastolic blood pressure (DBP), systolic blood pressure (SBP), years of dialysis (YD), heart rate (HR), and body mass index (BMI) are employed to construct our model. The summary of information is shown in Table 1 . This study is a retrospective study, and feature of patient is easy to obtain. We hope to provide patients with a non-invasive dry weight assessment method through machine learning models. The RBF neural network (Park and Sandberg, 1990 ) is composed of an input layer, a hidden layer, and an output layer, and is shown in Figure 1 . The feature of the hemodialysis patient can be fed into the RBF network for processing. Suppose that there are N samples containing d variables x i , y i , i = 1, 2, . . . , N . The output isy i ∈ R 1×q and input data x i ∈ R 1×d . In Figure 1 , the RBF network has three layers, which are the input, hidden, and output layers. The transformation from the input space to the hidden layer space is non-linear, and the transformation between the hidden layer and the output layer is linear. The fundamental of the RBFN is the RBF is the "base" of the hidden unit. The vector of input layer can be mapped to the space of the hidden layer without weight connection. The mapping relationship is determined with center point of hidden unit. In Figure 1 , the number of hidden layer nodes is p (p center points). The activation function of the RBF neural network can be represented as: where x i is a feature vector of sample, c j , j ∈ 1, 2, . . . , p is the vector of j-th center point, and σ is the width parameter of the function, which controls the radial range of the function. RBFN can be represented as: where matrix ∈ R N×p is the output of the hidden nodes. W ∈ R p×q is the weight matrix between output and hidden nodes. Y ∈ R N×q is the matrix of dependent variable. ∈ R N×p and W ∈ R p×q can be represented as: Frontiers in Physiology | www.frontiersin.org To train RBFN, 3 parameters should be solved: the center points of the basis function c j ∈ R 1×d , j ∈ 1, 2, . . . , p , width (σ), and weight matrix between the output and hidden layer W ∈ R p×q . In most cases, the self-organized selection center learning method is used: (1) unsupervised learning process, solving the center points and width of RBF, (2) supervised learning process, solving the weights W ∈ R p×q . First, select p centers for k-means clustering (p clusters). For the radial basis of the Gaussian kernel function, the width is solved by the formula: where σ max is the maximum distance between the selected center points. For W ∈ R p×q , the RBF network can be represented as: The gradient of Eq. 6 can be set as 0: For a new test sample x new , we can estimate y * new as: To further improve the generalization performance of the RBF network, a multi-view Laplacian-regularized RBF network is proposed. The unsupervised process of the first stage remains unchanged; we mainly improve the model in the second part. The objective function of Eq. 6 is revised as: where λ 1 and λ 2 denote the parameters of Laplacian and L 2 , 1norm term. L 2 , 1 -norm can be used to obtain a sparser solution during the training process, which makes the model more robust. ρ > 1, which is used to prevent the extreme situations of η v = 0 (or η v = 1). L v ∈ R N×N is the Laplacian matrix, which is employed to represent the manifold of samples. V is the number of views. L v is built by heat kernel matrix S v ∈ R N×N : In our study, we employ the following functions to construct the heat kernel matrix: where γ is a constant, and we set it as 1. Frontiers in Physiology | www.frontiersin.org The third term of ||W|| 2 2,1 cannot be diversified, so Eq. 9 is converted into: where G ∈ R p×p is a diagonal matrix, and i-th is an element: Since there are multiple variables (W, η v ) that need to be optimized, we first fix η v and optimize W. We initialize η We obtain the derivative of formula (14) for variable W: Then, we fix the variant W and optimize η v , v = 1, 2, . . . , V, which is related to: The above formula can be converted to a Lagrange function: We set η v and ξ to 0: Frontiers in Physiology | www.frontiersin.org . where η v can be estimated by: The process of MLapRBFN is listed in Algorithm 1 and (1) Using k-means to select p centers and width (σ ) for RBF function. Calculating the W (training set) and Laplacian matrices L v , v = 1, 2, . . . , V by Eqs 1, 10, and 11. Initializing η (0) v = 1/V, v = 1, 2, . . . , V; (2) Setting t = 0, estimate the initial W (0) with Eq. 7; (3) Update the G (t+1) with , v = 1, 2, . . . , Vvia Eq. 19; (7) Calculate the output matrix new (test set); (8) Predict y new,j , j = 1, 2, . . . , M byy * new = new W * . In this section, we perform 10-fold cross-validation (10-CV) to test the predictive performance of different models, the BCM device, multiple kernel support vector regression (MKSVR), linear regression (LR), back propagation-based artificial neural network [ANN (BP)], and multi-kernel ridge regression (MKRR). Some traditional assessment methods include correlation coefficient (R), R square, root mean square error (RMSE), empirical cumulative distribution plot (ECDP), and Bland-Altman analysis. In particular, The Bland-Altman analysis usually can evaluate the agreement between two methods, and determines whether the two methods can be replaced with each other. We obtain the optimal model parameters, such as the number of hidden layer nodes (the number of clusters), regularization parameters, and number of optimization iterations. First, we fix the number of iterations (tmax = 10) and regularization coefficients (λ 1 = 2 0 , λ 2 = 2 0 ), and adjust the number of hidden layer neurons. In Figure 3A , we test the number of nodes from 10 to 250 with step of 10. After adding 140 neuron nodes, RMSE tends to be flat. In addition, the RMSE also tends to remain unchanged (minimum) after 10 iterations ( Figure 3B ). Finally, we get the number of hidden layer nodes as 140 and times of iteration as 10, and adjust the regularization coefficient. The results are shown in Figure 4 , and the optimal coefficients are λ 1 = 2 −3 , λ 2 = 2 −3 . We compare our model with other existing machine learning methods , which include multi-kernel ridge regression (MKRR), multiple kernel support vector regression (MKSVR), artificial neural network (ANN), linear regression (LR), and BCM measuring instrument. The gold standard is clinical dry weight. In Table 2 In this section, we employ a Bland-Altman plot to further evaluate the regression error of different models. In Figure 6 and Table 3 , several models evaluate the agreement with clinical DW. MLapRBFN achieves the smallest range of -0.2413 to 0.1601 (95% confidence interval). What is more, the number (ratio) of out agreement interval is the key indicator to evaluate whether the two methods are equivalent. For the predictive models, the number (ratio) should be all less than 24 (5%). In Table 3 , all the predictive models meet this standard. In particular, our method obtains the least number (ratio) of 17 (3.57%). If 95% of the samples are in agreement range, the predictive models are clinically acceptable. It can be seen that our method can replace clinical methods. The limitations of BCM and clinical are time-consuming and laborious. In our study, a MLapRBFN method is developed to predict the DW of hemodialysis patients. Different from standard RBFN, our method contains multiple Laplace regularization terms, and uses an efficient iterative algorithm to solve the model. MKRR, LR, MKSVR, and ANN are compared with our model. Bland-Altman analysis and RMSE are the main evaluation methods. In the Bland-Altman analysis of MLapRBFN, the number of out agreement interval is the least (17 samples). In the fields of medicine (Esteva et al., 2017; Xiao et al., 2017; Hu et al., 2018; Deng et al., 2019; Huang et al., 2020; Zhou et al., 2020; Yang H. et al., 2021) , pharmacy , and biology (Wei et al., 2014 (Wei et al., , 2017 Fajila, 2019; Wang Y. et al., 2019; Wang et al., 2021; Yang C. et al., 2021; Zou et al., 2021) , artificial intelligence technology has solved lots of predictive tasks. In future studies, more data of hemodialysis patients will be collected, and a deep neural network (Dao et al., 2020a,b; Lv et al., 2020) with stronger representation ability to accurately estimate the DW of hemodialysis patients will be built. The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding authors. The studies involving human participants were reviewed and approved by the experimental protocol was established and approved by the Human Ethics Committee (Wuxi and Northern Jiangsu People's Hospital Ethics Committee). The ethical approval numbers are 2018KY-001 and KYLLKS201813. The patients/participants provided their written informed consent to participate in this study. XG and WZ did the experiments and wrote the manuscript. YD, CL, and XG designed the method. YY, YZ, AD, QL, and YC revised the manuscript. All authors have read and approved the final manuscript. Comparison of multiple fluid status assessment methods in patients on chronic hemodialysis Morbigenous brain region and gene detection with a genetically evolved random neural network cluster approach in late mild cognitive impairment Prediction of disease comorbidity using hetesim scores based on multiple heterogeneous networks IntNetLncSim: an integrative network analysis method to infer human lncRNA functional similarity Exposing the causal effect of body mass index on the risk of type 2 diabetes mellitus: a mendelian randomization study Applying an artificial neural network to predict total body water in hemodialysis patients Iterative feature representation algorithm to improve the predictive performance of N7-methylguanosine sites iDHS-Deep: an integrated tool for predicting DNase I hypersensitive sites by deep neural network DeepYY1: a deep learning approach to identify YY1-mediated chromatin loops A computational platform to identify origins of replication sites in eukaryotes Pathwayguided deep neural network toward interpretable and predictive modeling of drug sensitivity LDAH2V: exploring meta-paths across multiple networks for lncRNA-disease association prediction Deep neural networks for inferring binding sites of RNA-binding proteins by using distributed representations of RNA primary sequence and secondary structure MultiSourcDSim: an integrated approach for exploring disease similarity Identification of drug-side effect association via multiple information integration with centered kernel alignment Human protein subcellular localization identification via fuzzy model on kernelized neighborhood representation Identification of drug-target interactions via dual laplacian regularized least squares with multiple kernel fusion Identification of drug-target interactions via multi-view graph regularized link propagation model Identification of proteinnucleotide binding residues via graph regularized k-local hyperplane distance nearest neighbor model Dermatologist-level classification of skin cancer with deep neural networks Gene subset selection for leukemia classification using microarray data Circular RNAs serve as novel biomarkers and therapeutic targets in cancers Composition and management of hemodialysis fluids An efficient multiple kernel support vector regression model for assessing dry weight of hemodialysis patients SubtypeDrug: a software package for prioritization of candidate cancer subtype-specific drugs Integration of multiple-omics data to analyze the population-specific differences for coronary artery disease rs1990622 variant associates with Alzheimer's disease and regulates TMEM106B expression in human brain tissues rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences Identification of alzheimer's disease-related genes based on data integration method Melatonin inhibiting the survival of human gastric cancer cells under ER stress involving autophagy and Ras-Raf-MAPK signalling O-GlcNAcPRED-II: an integrated classification algorithm for identifying O-GlcNAcylation sites based on fuzzy undersampling and a K-means PCA oversampling technique Use of lung ultrasonography to determine the accuracy of clinically estimated dry weight in chronic hemodialysis patients Development and application of artificial intelligence methods in biological and medical data HITS-PR-HHblits: protein remote homology detection by combining pagerank and hyperlink-induced topic search Genetic variant rs17185536 regulates SIM1 gene expression in human brain hypothalamus Disease status affects the association between rs4813620 and the expression of Alzheimer's disease susceptibility gene TRIB3 Correction to 'DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy Classification and gene selection of triple-negative breast cancer subtype embedding gene connectivity matrix in deep neural network Deep-Kcr: accurate detection of lysine crotonylation sites using deep learning method DeepIPs: comprehensive assessment and computational identification of phosphorylation sites of SARS-CoV-2 infection using a deep learning-based approach A sequencebased deep learning approach to predict CTCF-mediated chromatin loop Universal approximation using radial basis function networks Application of machine learning in microbiology Incorporating distance-based top-n-gram and random forest to identify electron transport proteins Protein subcellular localization based on deep image features and criterion learning strategy Fusing convolutional neural network features with hand-crafted features for osteoporosis diagnoses Importance of whole-body bioimpedance spectroscopy for the management of fluid balance Identification of membrane protein types via multivariate information fusion with Hilbert-Schmidt Independence Criterion Exploring associations of non-coding RNAs in human diseases via three-matrix factorization with hypergraph-regular terms on center kernel alignment Predicting Drugtarget Interactions via FM-DNN Learning Morphological segmentation analysis and texture-based support vector machines classification on mice liver fibrosis microscopic images Prediction of human protein subcellular localization using deep learning Improved and promising identification of human MicroRNAs by incorporating a high-quality negative set Exploring sequencebased features for the improved prediction of DNA N4-methylcytosine sites in multiple species Integration of deep feature representations and handcrafted features to improve the prediction of N-6-methyladenosine sites A novel hierarchical selective ensemble classifier with bioinformatics application A deep learning-based multi-model ensemble method for cancer prediction Granular multiple kernel learning for identifying RNA-binding protein residues via integrating sequence and structure information Risk Prediction of Diabetes: Big data mining with fusion of multifarious physical examination indicators Prediction of potential diseaseassociated microRNAs using structural perturbation method Artificial intelligence for bioinformatics and biomedicine Integrating bipartite network projection and KATZ measure to identify novel CircRNA-disease associations Gene therapy for hemophilia a: where we stand Gene2vec: gene subsequence embedding for prediction of mammalian N6-Methyladenosine sites from mRNA MK-FSVM-SVDD: A Multiple Kernel-based Fuzzy SVM Model for Predicting DNAbinding Proteins via Support Vector Data Description The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.